Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Interest Coverage Ratio (2022 - 2025)

Phathom Pharmaceuticals (PHAT) has disclosed Interest Coverage Ratio for 4 consecutive years, with 0.36 as the latest value for Q4 2025.

  • On a quarterly basis, Interest Coverage Ratio rose 88.7% to 0.36 in Q4 2025 year-over-year; TTM through Dec 2025 was 2.35, a 39.04% increase, with the full-year FY2025 number at 2.35, up 39.04% from a year prior.
  • Interest Coverage Ratio was 0.36 for Q4 2025 at Phathom Pharmaceuticals, up from 0.95 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 0.36 in Q4 2025 to a low of 13.74 in Q1 2022.
  • A 4-year average of 4.45 and a median of 3.95 in 2024 define the central range for Interest Coverage Ratio.
  • Peak YoY movement for Interest Coverage Ratio: crashed 31.98% in 2024, then soared 88.7% in 2025.
  • Phathom Pharmaceuticals' Interest Coverage Ratio stood at 4.86 in 2022, then fell by 10.41% to 5.36 in 2023, then surged by 40.41% to 3.2 in 2024, then skyrocketed by 88.7% to 0.36 in 2025.
  • Per Business Quant, the three most recent readings for PHAT's Interest Coverage Ratio are 0.36 (Q4 2025), 0.95 (Q3 2025), and 3.42 (Q2 2025).